The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review

Overview of attention for article published in Frontiers in Pharmacology, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets

twitter: 8 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 52 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 2 outlets.

Multiple mechanisms, multiple benefits: SGLT2 inhibition shows promise in lupus, gout

Healio.com, 26 Jan 2024

Last November, at the American College of Rheumatology Convergence 2023, several faculty members presented new data on how a…

The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review

Doc Wire News, 22 Nov 2021

This article was originally published here Front Pharmacol. 2021 Nov 5;12:751214.

The Role of SGLT2 Inhibitors in Atherosclerosis: A Narrative Mini-Review

Doc Wire News, 22 Nov 2021

This article was originally published here Front Pharmacol. 2021 Nov 5;12:751214.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.